ID

24049

Beschreibung

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness; ODM derived from: https://clinicaltrials.gov/show/NCT00573950

Link

https://clinicaltrials.gov/show/NCT00573950

Stichworte

Versionen (1)
  1. 24.07.17 24.07.17 -
Hochgeladen am

24. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT00573950

Englisch

Eligibility Diabetes Mellitus, Type 2 NCT00573950

1 Formulare  
Criteria
Beschreibung

Criteria

type 2 diabetes (at least 1 criteria below)
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
1. fasting blood glucose ≥ 126 mg/dl
Beschreibung

Fasting blood glucose measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0428568
2. postprandial 2hour glucose ≥ 200 mg/dl
Beschreibung

2-hour postprandial blood glucose measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C2238058
3. random blood glucose ≥ 200 mg/dl with typical diabetes symptoms
Beschreibung

Random blood glucose measurement | Diabetes Mellitus Symptoms typical

Datentyp

boolean

Alias
UMLS CUI [1]
C0428567
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C1457887
UMLS CUI [2,3]
C3538928
metabolic syndrome : asian-pacific atp iii guideline
Beschreibung

Metabolic Syndrome

Datentyp

boolean

Alias
UMLS CUI [1]
C0524620
1. fasting blood glucose ≥ 110 mg/dl, or previously diagnosed type 2 diabetes
Beschreibung

Fasting blood glucose measurement | Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0428568
UMLS CUI [2]
C0011860
2. systolic and/or diastolic blood pressure ≥130/85 mmhg, or treatment of previously diagnosed hypertension
Beschreibung

Systolic Pressure | Diastolic blood pressure | Therapeutic procedure Hypertensive disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2]
C0428883
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0020538
3. triglyceride ≥ 150 mg/dl, or specific treatment for this lipid abnormality
Beschreibung

Triglycerides measurement | Therapeutic procedure Specific Lipids abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0202236
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0205369
UMLS CUI [2,3]
C0549634
4. hdl-cholesterol < 40 mg/dl for men and < 50 mg/dl for women, or specific treatment for this lipid abnormality
Beschreibung

Serum HDL cholesterol measurement | Gender | Therapeutic procedure Specific Lipids abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0428472
UMLS CUI [2]
C0079399
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0205369
UMLS CUI [3,3]
C0549634
5. waist circumference ≥ 90 for men and ≥ 80 for women
Beschreibung

Waist Circumference | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0455829
UMLS CUI [2]
C0079399
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
hypertensive patients with the use of ace inhibitor or arb
Beschreibung

Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Datentyp

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0003015
UMLS CUI [3]
C0521942
hyperlipidemic patients with the use of statin or fenofibrate
Beschreibung

Hyperlipidemia | Statin | Fenofibrate

Datentyp

boolean

Alias
UMLS CUI [1]
C0020473
UMLS CUI [2]
C0360714
UMLS CUI [3]
C0033228
hepatic dysfunction
Beschreibung

Liver Dysfunction

Datentyp

boolean

Alias
UMLS CUI [1]
C0086565
chronic alcohol or drug abuse
Beschreibung

Substance Use Disorders chronic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0205191
renal dysfunction
Beschreibung

Renal dysfunction

Datentyp

boolean

Alias
UMLS CUI [1]
C3279454
heart failure
Beschreibung

Heart failure

Datentyp

boolean

Alias
UMLS CUI [1]
C0018801
patients who takes hormone replace therapy or steroid containing drugs
Beschreibung

Hormone replacement therapy | Pharmaceutical Preparations Containing Steroids

Datentyp

boolean

Alias
UMLS CUI [1]
C0282402
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332256
UMLS CUI [2,3]
C0038317
patients who take drugs like anticoagulant (warfarin), anti-platelet agent (aspirin, ticlopidin), thrombolytic agent (urikinase, alteplase), prostaglandine e1 , drugs inhibit cyp3a4 or cyp2c19, or drugs become substrate of cyp3a4
Beschreibung

Anticoagulants | Warfarin | Antiplatelet Agents | Aspirin | Ticlopidine | Thrombolytic Agent | Urokinase | alteplase | Alprostadil | Cytochrome P450 3A4 Inhibitor | CYP2C19 Inhibitors | CYP3A4 Substrate

Datentyp

boolean

Alias
UMLS CUI [1]
C0003280
UMLS CUI [2]
C0043031
UMLS CUI [3]
C0085826
UMLS CUI [4]
C0004057
UMLS CUI [5]
C0040207
UMLS CUI [6]
C3536865
UMLS CUI [7]
C0042071
UMLS CUI [8]
C0032143
UMLS CUI [9]
C0002335
UMLS CUI [10]
C3830624
UMLS CUI [11]
C3850059
UMLS CUI [12,1]
C3714798
UMLS CUI [12,2]
C3891814
patients who haves disease influencing the results of the study such as neurologic, digestive and neoplastic disease
Beschreibung

Disease Affecting Research results | nervous system disorder | Digestive System Disorders | Neoplastic disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0683954
UMLS CUI [2]
C0027765
UMLS CUI [3]
C0012242
UMLS CUI [4]
C1882062
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT00573950

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes (at least 1 criteria below)
boolean
C0011860 (UMLS CUI [1])
Fasting blood glucose measurement
Item
1. fasting blood glucose ≥ 126 mg/dl
boolean
C0428568 (UMLS CUI [1])
2-hour postprandial blood glucose measurement
Item
2. postprandial 2hour glucose ≥ 200 mg/dl
boolean
C2238058 (UMLS CUI [1])
Random blood glucose measurement | Diabetes Mellitus Symptoms typical
Item
3. random blood glucose ≥ 200 mg/dl with typical diabetes symptoms
boolean
C0428567 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
C3538928 (UMLS CUI [2,3])
Metabolic Syndrome
Item
metabolic syndrome : asian-pacific atp iii guideline
boolean
C0524620 (UMLS CUI [1])
Fasting blood glucose measurement | Diabetes Mellitus, Non-Insulin-Dependent
Item
1. fasting blood glucose ≥ 110 mg/dl, or previously diagnosed type 2 diabetes
boolean
C0428568 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Systolic Pressure | Diastolic blood pressure | Therapeutic procedure Hypertensive disease
Item
2. systolic and/or diastolic blood pressure ≥130/85 mmhg, or treatment of previously diagnosed hypertension
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0020538 (UMLS CUI [3,2])
Triglycerides measurement | Therapeutic procedure Specific Lipids abnormal
Item
3. triglyceride ≥ 150 mg/dl, or specific treatment for this lipid abnormality
boolean
C0202236 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C0549634 (UMLS CUI [2,3])
Serum HDL cholesterol measurement | Gender | Therapeutic procedure Specific Lipids abnormal
Item
4. hdl-cholesterol < 40 mg/dl for men and < 50 mg/dl for women, or specific treatment for this lipid abnormality
boolean
C0428472 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0205369 (UMLS CUI [3,2])
C0549634 (UMLS CUI [3,3])
Waist Circumference | Gender
Item
5. waist circumference ≥ 90 for men and ≥ 80 for women
boolean
C0455829 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
hypertensive patients with the use of ace inhibitor or arb
boolean
C0020538 (UMLS CUI [1])
C0003015 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
Hyperlipidemia | Statin | Fenofibrate
Item
hyperlipidemic patients with the use of statin or fenofibrate
boolean
C0020473 (UMLS CUI [1])
C0360714 (UMLS CUI [2])
C0033228 (UMLS CUI [3])
Liver Dysfunction
Item
hepatic dysfunction
boolean
C0086565 (UMLS CUI [1])
Substance Use Disorders chronic
Item
chronic alcohol or drug abuse
boolean
C0038586 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Renal dysfunction
Item
renal dysfunction
boolean
C3279454 (UMLS CUI [1])
Heart failure
Item
heart failure
boolean
C0018801 (UMLS CUI [1])
Hormone replacement therapy | Pharmaceutical Preparations Containing Steroids
Item
patients who takes hormone replace therapy or steroid containing drugs
boolean
C0282402 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0038317 (UMLS CUI [2,3])
Anticoagulants | Warfarin | Antiplatelet Agents | Aspirin | Ticlopidine | Thrombolytic Agent | Urokinase | alteplase | Alprostadil | Cytochrome P450 3A4 Inhibitor | CYP2C19 Inhibitors | CYP3A4 Substrate
Item
patients who take drugs like anticoagulant (warfarin), anti-platelet agent (aspirin, ticlopidin), thrombolytic agent (urikinase, alteplase), prostaglandine e1 , drugs inhibit cyp3a4 or cyp2c19, or drugs become substrate of cyp3a4
boolean
C0003280 (UMLS CUI [1])
C0043031 (UMLS CUI [2])
C0085826 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
C0040207 (UMLS CUI [5])
C3536865 (UMLS CUI [6])
C0042071 (UMLS CUI [7])
C0032143 (UMLS CUI [8])
C0002335 (UMLS CUI [9])
C3830624 (UMLS CUI [10])
C3850059 (UMLS CUI [11])
C3714798 (UMLS CUI [12,1])
C3891814 (UMLS CUI [12,2])
Disease Affecting Research results | nervous system disorder | Digestive System Disorders | Neoplastic disease
Item
patients who haves disease influencing the results of the study such as neurologic, digestive and neoplastic disease
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C0027765 (UMLS CUI [2])
C0012242 (UMLS CUI [3])
C1882062 (UMLS CUI [4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video